NCT04393805 Heparins for Thromboprophylaxis in COVID-19 Patients: HETHICO Study in Veneto Status COMPLETED Phase N/A
NCT04393428 Urinary Biomarkers for AKI Diagnosis in Patients With SARS-CoV-2 (COVID-19) Status COMPLETED Phase N/A
NCT04393311 Ulinastatin for the Treatment of COVID-19 in Hospitalized Patients Status WITHDRAWN Phase PHASE1/PHASE2
NCT04393246 mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Experimental Drugs and Mechanisms Status COMPLETED Phase PHASE2/PHASE3
NCT04393051 Baricitinib Compared to Standard Therapy in Patients With COVID-19 Status UNKNOWN Phase PHASE2
NCT04393038 ABX464 in Treating Inflammation and Preventing Acute Respiratory Failure in Patients With COVID-19 Status TERMINATED Phase PHASE2/PHASE3
NCT04392414 Hyperimmune Convalescent Plasma in Moderate and Severe COVID-19 Disease Status COMPLETED Phase PHASE2
NCT04392232 A Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection Status COMPLETED Phase PHASE2
NCT04392141 Colchicine Plus Phenolic Monoterpenes to Treat COVID-19 Status COMPLETED Phase PHASE1/PHASE2
NCT04392089 Effects of Cardiovascular and Pulmonary Optimization on Cerebral Oxygenation in COVID-19 Patients With Severe ARDS Status UNKNOWN Phase N/A
NCT04391712 Photobiomodulation Laser Therapy for COVID-19 Positive Patients With Pulmonary Disease Status COMPLETED Phase PHASE2
NCT04391686 Resting Energy Expenditure of the COronaVirus (COVID19) Patient in Reanimation Context Status COMPLETED Phase N/A
NCT04391179 Dipyridamole to Prevent Coronavirus Exacerbation of Respiratory Status (DICER) in COVID-19 Status COMPLETED Phase PHASE2
NCT04391127 Hydroxychloroquine and Ivermectin for the Treatment of COVID-19 Infection Status COMPLETED Phase PHASE3
NCT04390594 Efficacy and Safety Evaluation of Treatment Regimens in Adult COVID-19 Patients in Senegal Status TERMINATED Phase PHASE3